But new research from Rockefeller University, published in the Feb. 26 online edition of Proceedings of the National Academy of Sciences, has identified a therapeutic target, called casein kinase 1, that may be the key to halting the course of the disease. The findings, based on studies in mammalian cells, show that chemicals that block casein kinase 1 don't interfere with a closely connected essential pathway.
Alzheimer's disease is caused by a build-up of a small protein called beta-amyloid, which is formed when a larger protein is broken into pieces. But the enzyme that produces beta-amyloid is also responsible for cleavage of another protein called Notch. The problem with current drugs is that they block these enzymes to stop production of beta-amyloid, and in doing so they also block the cleavage of Notch -- which plays an important role in the development of healthy brain cells.
The new research, based on studies by lead author Marc Flajolet and from the Nobel Prize winning laboratory of Paul Greengard, director of the Fisher Center for Alzheimer's Disease Research at Rockefeller, has identified another protein, casein kinase 1, that controls the regulation of these enzymes. When the researchers block casein kinase 1, production of beta-amyloid proteins goes down, but Notch signaling is not affected.
"Studies of brain tissue from Alzheimer's patients have shown an increase in casein kinase 1 expression," says Greengard, Vincent Astor Professor and head of the Laboratory of Molecular and Cellular Neuroscience. "We found that the key enzymes involved in beta-amyloid production – called BACE and gamma-secretase – were targets of casein kinase 1, so we investigated what role it might be playing."
The scientists modified mouse cells to generate a form of casein kinase 1 that was always active, and found that these cells produced more beta-amyloid protein than normal. Then, using three different types of chemicals, they blocked the protein from functioning. When they did this, they were able to reverse the production of beta-amyloid protein, without affecting the signaling of Notch proteins.
The studies suggest that an Alzheimer's therapy based on these chemicals could reduce or halt beta-amyloid build-up without causing side effects. "Numerous efforts have been directed at the development of drugs that inhibit gamma-secretase," says Greengard, "but there have been significant side effects in animal studies. Our hope is that this research might lead to drugs that don't have those problems."
Kristine Kelly | EurekAlert!
Switch-in-a-cell electrifies life
18.12.2018 | Rice University
Plant biologists identify mechanism behind transition from insect to wind pollination
18.12.2018 | University of Toronto
Researchers from the University of Basel have reported a new method that allows the physical state of just a few atoms or molecules within a network to be controlled. It is based on the spontaneous self-organization of molecules into extensive networks with pores about one nanometer in size. In the journal ‘small’, the physicists reported on their investigations, which could be of particular importance for the development of new storage devices.
Around the world, researchers are attempting to shrink data storage devices to achieve as large a storage capacity in as small a space as possible. In almost...
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
18.12.2018 | Materials Sciences
18.12.2018 | Physics and Astronomy
18.12.2018 | Physics and Astronomy